NICE clinical guideline (CG152): The management of Crohn's disease in adults, children and young people

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 2, 2013, Pages 195-203

  Mayberry, J F ^a   Lobo, A ^b   Ford, A C ^c   Thomas, A ^d  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; GLUCOCORTICOID; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; THIOPURINE METHYLTRANSFERASE;

BALLOON DILATATION; CLINICAL EFFECTIVENESS; COLONOSCOPY; CONTRACEPTION; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DISEASE EXACERBATION; DRUG MONITORING; ENTERIC FEEDING; EVIDENCE BASED PRACTICE; FOLLOW UP; FRAGILITY FRACTURE; HUMAN; ILEUM; INTESTINE STENOSIS; MAINTENANCE THERAPY; META ANALYSIS (TOPIC); MONOTHERAPY; NEUTROPENIA; OSTEOPENIA; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REMISSION; REVIEW; SECONDARY OSTEOPOROSIS; SYSTEMATIC REVIEW; TREATMENT FAILURE; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AZATHIOPRINE; CHILD; COST-BENEFIT ANALYSIS; CROHN DISEASE; DISEASE MANAGEMENT; FEMALE; GLUCOCORTICOIDS; GREAT BRITAIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREGNANCY; STATE MEDICINE; YOUNG ADULT;

EID: 84872870746     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12102     Document Type: Review

References (14)

1. Rubin GP, Hungin AP, Kelly PJ, Ling J,. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000; 14: 1553-9.
2. Steed H, Walsh S, Reynolds N,. Crohn's disease incidence in NHS Tayside. Scott Med J 2010; 55: 22-5.
3. Gomez J,. Living with Crohn's Disease (Overcoming Common Problems). London: Sheldon Press, 2000.
4. Engstrom I,. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J Child Psychol Psychiatry 1992; 33: 563-82.
5. Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F,. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002; 97: 1994-9.
6. National Clinical Guideline Centre. The Management of Crohn's Disease. Appendix A: Scope [October 19, 2012]. London: Royal College of Physicians, 2012. Available at: http://guidance.nice.org.uk/CG152/Guidance/Appendices/pdf/ English. Accessed October 19, 2012.
7. National Institute for Health and Clinical Excellence. The Guidelines Manual. London: National Institute for Health and Clinical Excellence, 2009. Available at: http://www.nice.org.uk/aboutnice/howwework/ developingniceclinicalguidelines/clinicalguidelinedevelopmentmethods/ GuidelinesManual2009.jsp. Accessed October 19, 2012.
8. Caldwell DM, Ades AE, Higgins JP,. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331: 897-900.
9. Dias S, Welton NJ, Sutton AJ, Ades AE,. NICE DSU Technical Support Document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. 2011. Available at: http://www.nicedsu.org.uk. Accessed October 19, 2012.
10. GRADE Working Group. The grading of recommendations assessment, development and evaluation (GRADE) working group website. 2011. Available at: http://www.gradeworkinggroup.org. Accessed October 19, 2012.
11. National Clinical Guideline Centre. Patient Experience in Adult NHS Services: Improving the Experience of Care for People Using Adult NHS Services. NICE Clinical Guideline CG138. London: Royal College of Physicians, 2012. Available at: http://guidance.nice.org.uk/CG138. Accessed October 19, 2012.
12. National Institute for Health and Clinical Excellence. NICE Technology Appraisal Guidance 187. Infliximab (Review) and Adalimumab for the Treatment of Crohn's Disease. Includes a Review of NICE Technology Appraisal Guidance 40. 2010. Available at: http://guidance.nice.org.uk/TA187. Accessed October 19, 2012.
13. National Clinical Guideline Centre. Osteoporosis: Assessing the Risk of Fragility Fracture. London: Royal College of Physicians, 2012. Available at: http://guidance.nice.org.uk/CG146. Accessed October 19, 2012.
14. National Clinical Guideline Centre. The Management of Crohn's Disease. Appendix H: Full health economics report [October 2012]. London: Royal College of Physicians, 2012. Available at: http://guidance.nice.org.uk/CG152/Guidance/ Appendices/pdf/English. Accessed October 19, 2012.